Skip to main content
. 2010 Aug;21(8):1371–1380. doi: 10.1681/ASN.2009121208

Table 2.

Comparison of imaging parameters for patients with CKD and with and without fractures

Parameter Fracture (mean ± SD) No Fracture (mean ± SD) % Difference OR (95% CI) AUC (95% CI)
DXA
    total LS BMD (g/cm2) 0.957 ± 0.173 1.069 ± 0.203a −10 1.93 (1.15 to 3.25) 0.66 (0.54 to 0.78)
    total LS T score −1.1 ± 1.5 −0.1 ± 1.8a 1.91 (1.15 to 3.17) 0.67 (0.55 to 0.78)
    TH BMD (g/cm2) 0.840 ± 0.171 0.923 ± 0.176b −9 1.65 (1.02 to 2.67) 0.63 (0.50 to 0.75)
    TH T score −1.2 ± 1.1 −0.7 ± 1.1 1.60 (0.98 to 2.58) 0.61 (0.49 to 0.73)
    FN BMD (g/cm2) 0.677 ± 0.127 0.755 ± 0.154b −10 1.86 (1.10 to 3.14) 0.66 (0.55 to 0.78)
    FN T score −1.9 ± 0.9 −1.4 ± 1.1b 1.76 (1.05 to 2.99) 0.62 (0.50 to 0.75)
    1/3R BMD (g/cm2) 0.652 ± 0.107 0.697 ± 0.117 −7 1.51 (0.96 to 2.37) 0.60 (0.48 to 0.72)
    1/3R T score −1.6 ± 1.8 −1.2 ± 1.4 1.30 (0.84 to 2.02) 0.52 (0.39 to 0.65)
    UDR BMD (g/cm2) 0.363 ± 0.084 0.430 ± 0.093a −16 2.29 (1.34 to 3.89) 0.68 (0.57 to 0.80)
    UDR T score −2.1 ± 1.4 −1.3 ± 1.2c 1.94 (1.17 to 3.21) 0.62 (0.50 to 0.75)
HRpQCT, radius
    total area (mm2) 274 ± 59 293 ± 73 −6 1.33 (0.85 to 2.08) 0.56 (0.44 to 0.69)
    CtArea (mm2) 45 ± 15 55 ± 19a −18 1.85 (1.12 to 3.08) 0.63 (0.51 to 0.75)
    trabecular area (mm2) 228 ± 53 237 ± 69 −4 1.15 (0.74 to 1.79) 0.52 (0.40 to 0.65)
    Dtot (mg HA/cm3) 255 ± 63 300 ± 71a −15 2.11 (1.24 to 3.57) 0.66 (0.54 to 0.77)
    Dcort (mg HA/cm3) 801 ± 82 825 ± 81 −3 1.35 (0.87 to 2.10) 0.56 (0.43 to 0.68)
    Dtrab (mg HA/cm3) 122 ± 43 151 ± 48a −19 2.01 (1.21 to 3.34) 0.65 (0.53 to 0.77)
    BV/TV (%) 10.2 ± 3.6 12.6 ± 4.0a −19 2.01 (1.21 to 3.35) 0.65 (0.53 to 0.76)
    CtTh (μm) 626 ± 179 743 ± 241b −16 1.78 (1.09 to 2.91) 0.61 (0.49 to 0.73)
    TbN (1/mm) 1.7 ± 0.5 2.0 ± 0.4b −12 1.79 (1.13 to 2.83) 0.64 (0.52 to 0.77)
    trabecular thickness (μm) 59 ± 13 64 ± 13 −8 1.62 (0.98 to 2.70) 0.58 (0.45 to 0.71)
    TbSp (μm) 574 ± 206 477 ± 164b 20 1.71 (1.07 to 2.74) 0.65 (0.53 to 0.78)
    TbSpSD (1/μm) 315 ± 214 218 ± 146a 44 1.76 (1.07 to 2.91) 0.65 (0.53 to 0.78)
HRpQCT, tibia
    total area (mm2) 769 ± 139 771 ± 147 −0.3 1.02 (0.66 to 1.57) 0.50 (0.37 to 0.63)
    CtArea (mm2) 90 ± 46 110 ± 38b −18 1.73 (1.04 to 2.88) 0.67 (0.55 to 0.79)
    trabecular area (mm2) 679 ± 133 662 ± 143 3 0.88 (0.57 to 1.36) 0.55 (0.42 to 0.67)
    Dtot (mg HA/cm3) 226 ± 56 259 ± 63b −13 1.85 (1.11 to 3.09) 0.65 (0.53 to 0.76)
    Dcort (mg HA/cm3) 744 ± 87 786 ± 77b −5 1.70 (1.07 to 2.68) 0.62 (0.50 to 0.74)
    Dtrab (mg HA/cm3) 142 ± 37 158 ± 48 −10 1.48 (0.92 to 2.37) 0.57 (0.45 to 0.70)
    BV/TV (%) 11.8 ± 3.1 13.2 ± 4.0 −10 1.48 (0.92 to 2.38) 0.58 (0.45 to 0.70)
    CtTh (μm) 793 ± 374 979 ± 338b −19 1.82 (1.09 to 3.02) 0.68 (0.56 to 0.80)
    TbN (1/mm) 1.7 ± 0.4 1.9 ± 0.5 −8 1.44 (0.92 to 2.25) 0.58 (0.46 to 0.70)
    trabecular thickness (μm) 68 ± 12 69 ± 10 −2 1.11 (0.71 to 1.72) 0.56 (0.43 to 0.68)
    TbSp (μm) 542 ± 189 494 ± 179 10 1.29 (0.84 to 1.98) 0.58 (0.46 to 0.70)
    TbSpSD (1/μm) 292 ± 232 248 ± 163 18 1.25 (0.82 to 1.92) 0.56 (0.44 to 0.68)

aP < 0.01.

bP < 0.05.

cP < 0.001.

HHS Vulnerability Disclosure